SOCIETY FOR ECONOMIC ANALYSIS LIMITED
The principal activity is the promotion of both the production and dissemination of high quality research in the general area of Economics, with particular emphasis on the support of young researchers.
Financial health, per its FY2024 accounts
The accounts state that free reserves were just over £556k, which is below the trustees' stated policy target of covering five years of expenditure (approx. £2.5m). The charity reported a net expenditure for the year, with reserves increasing largely due to unrealised investment gains rather than operational surplus.
What the accounts disclose
“Gift Aid distribution from trading subsidiary” — page 11
“it was agreed that available reserves should be sufficient to cover at least five years of direct and overhead expenditure of both the charity and its trading subsidiary.”
“The charity has a 100% interest in Review of Economic Studies Limited (working name "RESL"), a company that publishes an academic economics journal. The charity is dependent on RESL for the majority of its income.” — page 7
“The mechanism for this is to trade through a wholly owned subsidiary company, Review of Economic Studies Limited.” — page 2
Trustees
- Dr Swati Dhingra
- Professor Andrea Galeotti
- Professor Davide Werner Cantoni
- Professor FLORIAN SCHEUER
- Professor Kalina Manova
- Professor MARIA PETROVA
- Professor RUBEN ENIKLOPOV
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £52k | £119k |
| 31/12/2023 | £188k | £107k |
| 31/12/2022 | £150k | £147k |
| 31/12/2021 | £250k | £24k |
| 31/12/2020 | £313k | £7k |
Common questions
Is SOCIETY FOR ECONOMIC ANALYSIS LIMITED financially healthy?
Per its FY2024 accounts: The accounts state that free reserves were just over £556k, which is below the trustees' stated policy target of covering five years of expenditure (approx. £2.5m). The charity reported a net expenditure for the year, with reserves increasing largely due to unrealised investment gains rather than operational surplus. Its FY2024 accounts were independently examined.